You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 59 No. 1, JANUARY 1937 TABLE OF CONTENTS
  Archives
  •  Online Features
  Book Reviews
 This Article
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

By-Effects in Salvarsan Therapy and Their Prevention.

By Dr. V. Genner. Price, 22 kroner. Pp. 360. Copenhagen: Levin & Munksgaard, 1936.

Arch Intern Med. 1937;59(1):173.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

This monograph, compiled from the experience of the University Clinic of Dermatovenerology, at Copenhagen, assembles a mass of clinical data regarding arsenic intoxication during the treatment of syphilis. The entire subject, of course, is of great interest and has been widely studied; it must have been tedious work to gather together the very extensive literature which is reviewed, to assemble it properly and to add observations regarding it.

First, there is discussed the theoretical basis for arsenic intoxication; then there follow chapters on arsphenamine erythema, jaundice, albuminuria and what the author calls "paratherapeutic joint complaints." These chapters lead to a discussion as to how such uncomfortable by-effects of arsphenamine therapy may be avoided, especially by the use of a concentrated dextrose solution as a solvent for the arsphenamine. Finally the author pleads for individualization of antisyphilitic treatment; for, he claims, it is possible before treatment is begun to determine whether . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1937 American Medical Association. All Rights Reserved.